Srikanth Radhakrishnan
CIK: 0002098678
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Pulmonx Corp
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Sep 1, 2026LUNG
Pulmonx Corp
Sale(S)Direct5.9K shares at avg. $2.26$13K - Sep 1, 2026LUNG
Pulmonx Corp
Sale(S)Direct3.6K shares at avg. $2.26$8K - Sep 1, 2026LUNG
Pulmonx Corp
Sale(S)Direct2.1K shares at avg. $2.26$5K - Sep 1, 2026LUNG
Pulmonx Corp
Sale(S)Direct2.6K shares at avg. $2.26$6K - Jun 1, 2026LUNG
Pulmonx Corp
Sale(S)Direct2.7K shares at avg. $1.54$4K - Jun 1, 2026LUNG
Pulmonx Corp
Sale(S)Direct2.2K shares at avg. $1.54$3K - Jun 1, 2026LUNG
Pulmonx Corp
Sale(S)Direct3.7K shares at avg. $1.54$6K - Jun 1, 2026LUNG
Pulmonx Corp
Sale(S)Direct6K shares at avg. $1.54$9K - Mar 2, 2026LUNG
Pulmonx Corp
Award(A)Direct175K shares- - Mar 2, 2026LUNG
Pulmonx Corp
Sale(S)Direct4.2K shares at avg. $1.43$6K - Mar 2, 2026LUNG
Pulmonx Corp
Sale(S)Direct2.5K shares at avg. $1.43$4K - Mar 2, 2026LUNG
Pulmonx Corp
Sale(S)Direct3.1K shares at avg. $1.43$4K - Mar 2, 2026LUNG
Pulmonx Corp
Sale(S)Direct756 shares at avg. $1.43$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | LUNG Pulmonx Corp | Sale(S) | 5,863 | $2.26 | $13,250 | Direct |
| Sep 1, 2026 | LUNG Pulmonx Corp | Sale(S) | 3,618 | $2.26 | $8,177 | Direct |
| Sep 1, 2026 | LUNG Pulmonx Corp | Sale(S) | 2,121 | $2.26 | $4,793 | Direct |
| Sep 1, 2026 | LUNG Pulmonx Corp | Sale(S) | 2,643 | $2.26 | $5,973 | Direct |
| Jun 1, 2026 | LUNG Pulmonx Corp | Sale(S) | 2,691 | $1.54 | $4,144 | Direct |
| Jun 1, 2026 | LUNG Pulmonx Corp | Sale(S) | 2,153 | $1.54 | $3,316 | Direct |
| Jun 1, 2026 | LUNG Pulmonx Corp | Sale(S) | 3,684 | $1.54 | $5,673 | Direct |
| Jun 1, 2026 | LUNG Pulmonx Corp | Sale(S) | 5,969 | $1.54 | $9,192 | Direct |
| Mar 2, 2026 | LUNG Pulmonx Corp | Award(A) | 175,000 | - | $0 | Direct |
| Mar 2, 2026 | LUNG Pulmonx Corp | Sale(S) | 4,198 | $1.43 | $6,003 | Direct |
| Mar 2, 2026 | LUNG Pulmonx Corp | Sale(S) | 2,461 | $1.43 | $3,519 | Direct |
| Mar 2, 2026 | LUNG Pulmonx Corp | Sale(S) | 3,068 | $1.43 | $4,387 | Direct |
| Mar 2, 2026 | LUNG Pulmonx Corp | Sale(S) | 756 | $1.43 | $1,081 | Direct |
1-13 of 13 transactions
About Radhakrishnan Srikanth
Radhakrishnan Srikanth (SEC CIK 0002098678) files insider reports with the SEC as Chief Science & Techn. Officer of Pulmonx Corp (LUNG).
Signal8 holds 4 ownership filings by Radhakrishnan Srikanth (1 Form 3, 3 Form 4), filed between Dec 10, 2025 and Sep 3, 2026. Those filings report 13 transactions, from Mar 2, 2026 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Radhakrishnan Srikanth's filings is in REDWOOD CITY, CA.
Recent filings by Radhakrishnan Srikanth
Other insiders filing for Pulmonx Corp (LUNG)
- French Glendon E. III, President and CEO
- Lehman David Aaron, General Counsel
- Rose Geoffrey Beran, Chief Commercial Officer
- Burns Thomas William, Director
- Ferrari Richard, Director
- Florin Daniel P, Director